• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖皮质激素诱导亮氨酸拉链蛋白(GILZ)在炎症性骨质流失中的作用。

Role of glucocorticoid-induced leucine zipper (GILZ) in inflammatory bone loss.

作者信息

Yang Nianlan, Baban Babak, Isales Carlos M, Shi Xing-Ming

机构信息

Departments of Neuroscience & Regenerative Medicine, Augusta University, Augusta, GA, United States of America.

Departments of Oral Biology, Augusta University, Augusta, GA, United States of America.

出版信息

PLoS One. 2017 Aug 3;12(8):e0181133. doi: 10.1371/journal.pone.0181133. eCollection 2017.

DOI:10.1371/journal.pone.0181133
PMID:28771604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5542557/
Abstract

TNF-α plays a key role in the development of rheumatoid arthritis (RA) and inflammatory bone loss. Unfortunately, treatment of RA with anti-inflammatory glucocorticoids (GCs) also causes bone loss resulting in osteoporosis. Our previous studies showed that overexpression of glucocorticoid-induced leucine zipper (GILZ), a mediator of GC's anti-inflammatory effect, can enhance osteogenic differentiation in vitro and bone acquisition in vivo. To investigate whether GILZ could antagonize TNF-α-induced arthritic inflammation and protect bone in mice, we generated a TNF-α-GILZ double transgenic mouse line (TNF-GILZ Tg) by crossbreeding a TNF-α Tg mouse, which ubiquitously expresses human TNF-α, with a GILZ Tg mouse, which expresses mouse GILZ under the control of a 3.6kb rat type I collagen promoter fragment. Results showed that overexpression of GILZ in bone marrow mesenchymal stem/progenitor cells protected mice from TNF-α-induced inflammatory bone loss and improved bone integrity (TNF-GILZ double Tg vs. TNF-αTg, n = 12-15). However, mesenchymal cell lineage restricted GILZ expression had limited effects on TNF-α-induced arthritic inflammation as indicated by clinical scores and serum levels of inflammatory cytokines and chemokines.

摘要

肿瘤坏死因子-α(TNF-α)在类风湿性关节炎(RA)的发展以及炎症性骨质流失过程中发挥关键作用。遗憾的是,使用抗炎糖皮质激素(GCs)治疗RA也会导致骨质流失,进而引发骨质疏松。我们之前的研究表明,糖皮质激素诱导亮氨酸拉链(GILZ)作为GC抗炎作用的一种介质,其过表达能够在体外增强成骨分化,并在体内促进骨质生成。为了探究GILZ是否能够拮抗TNF-α诱导的小鼠关节炎炎症并保护骨骼,我们通过将广泛表达人TNF-α的TNF-α转基因小鼠与在3.6kb大鼠I型胶原启动子片段控制下表达小鼠GILZ的GILZ转基因小鼠杂交,培育出了TNF-α-GILZ双转基因小鼠品系(TNF-GILZ Tg)。结果显示,骨髓间充质干/祖细胞中GILZ的过表达保护小鼠免受TNF-α诱导的炎症性骨质流失,并改善了骨骼完整性(TNF-GILZ双转基因小鼠与TNF-α转基因小鼠相比,n = 12 - 15)。然而,如临床评分以及炎症细胞因子和趋化因子的血清水平所示,间充质细胞谱系受限的GILZ表达对TNF-α诱导的关节炎炎症影响有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/105e/5542557/bd06a050dcef/pone.0181133.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/105e/5542557/0efbe38d20ee/pone.0181133.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/105e/5542557/70738c22a3e0/pone.0181133.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/105e/5542557/3ff60312ac65/pone.0181133.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/105e/5542557/88820c46f611/pone.0181133.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/105e/5542557/bd06a050dcef/pone.0181133.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/105e/5542557/0efbe38d20ee/pone.0181133.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/105e/5542557/70738c22a3e0/pone.0181133.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/105e/5542557/3ff60312ac65/pone.0181133.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/105e/5542557/88820c46f611/pone.0181133.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/105e/5542557/bd06a050dcef/pone.0181133.g005.jpg

相似文献

1
Role of glucocorticoid-induced leucine zipper (GILZ) in inflammatory bone loss.糖皮质激素诱导亮氨酸拉链蛋白(GILZ)在炎症性骨质流失中的作用。
PLoS One. 2017 Aug 3;12(8):e0181133. doi: 10.1371/journal.pone.0181133. eCollection 2017.
2
Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression.糖皮质激素诱导亮氨酸拉链蛋白(GILZ)介导糖皮质激素作用并抑制炎性细胞因子诱导的COX-2表达。
J Cell Biochem. 2008 Apr 15;103(6):1760-71. doi: 10.1002/jcb.21562.
3
Glucocorticoid-induced leucine zipper (GILZ) antagonizes TNF-α inhibition of mesenchymal stem cell osteogenic differentiation.糖皮质激素诱导亮氨酸拉链(GILZ)拮抗 TNF-α 抑制间充质干细胞成骨分化。
PLoS One. 2012;7(3):e31717. doi: 10.1371/journal.pone.0031717. Epub 2012 Mar 2.
4
Crosstalk between bone marrow-derived mesenchymal stem cells and regulatory T cells through a glucocorticoid-induced leucine zipper/developmental endothelial locus-1-dependent mechanism.骨髓间充质干细胞与调节性T细胞之间通过糖皮质激素诱导亮氨酸拉链/发育性内皮位点-1依赖性机制的串扰。
FASEB J. 2015 Sep;29(9):3954-63. doi: 10.1096/fj.15-273664. Epub 2015 Jun 2.
5
Glucocorticoid-induced leucine zipper governs the therapeutic potential of mesenchymal stem cells by inducing a switch from pathogenic to regulatory Th17 cells in a mouse model of collagen-induced arthritis.糖皮质激素诱导亮氨酸拉链通过在胶原诱导性关节炎的小鼠模型中诱导致病性 Th17 细胞向调节性 Th17 细胞的转变来控制间充质干细胞的治疗潜力。
Arthritis Rheumatol. 2015 Jun;67(6):1514-24. doi: 10.1002/art.39069.
6
Role of glucocorticoid-induced leucine zipper (GILZ) in bone acquisition.糖皮质激素诱导亮氨酸拉链蛋白(GILZ)在骨骼发育中的作用。
J Biol Chem. 2014 Jul 11;289(28):19373-82. doi: 10.1074/jbc.M113.535237. Epub 2014 May 23.
7
Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis.糖皮质激素诱导亮氨酸拉链蛋白是关节炎中的一种内源性抗炎介质。
Arthritis Rheum. 2010 Sep;62(9):2651-61. doi: 10.1002/art.27566.
8
Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis.糖皮质激素诱导亮氨酸拉链在Th1介导的结肠炎模型中具有保护作用。
Gastroenterology. 2009 Feb;136(2):530-41. doi: 10.1053/j.gastro.2008.09.024. Epub 2008 Sep 25.
9
The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing's syndrome and may play a role in glucocorticoid-induced osteoporosis.糖皮质激素诱导的亮氨酸拉链基因(GILZ)在成功治疗内源性库欣综合征患者后表达下降,可能在糖皮质激素诱导的骨质疏松症中起作用。
J Clin Endocrinol Metab. 2010 Jan;95(1):246-55. doi: 10.1210/jc.2009-0595. Epub 2009 Oct 29.
10
The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells.糖皮质激素的抗炎作用是由上皮细胞中糖皮质激素诱导的亮氨酸拉链介导的。
J Allergy Clin Immunol. 2007 Jan;119(1):115-22. doi: 10.1016/j.jaci.2006.08.027. Epub 2006 Oct 13.

引用本文的文献

1
Synthesis and Anti-Cancer Activity of the Novel Selective Glucocorticoid Receptor Agonists of the Phenylethanolamine Series.新型苯乙胺类选择性糖皮质激素受体激动剂的合成及抗癌活性。
Int J Mol Sci. 2024 Aug 15;25(16):8904. doi: 10.3390/ijms25168904.
2
Reprofiling synthetic glucocorticoid-induced leucine zipper fusion peptide as a novel and effective hair growth promoter.重新剖析合成糖皮质激素诱导的亮氨酸拉链融合肽作为一种新型有效的头发生长促进剂。
Arch Dermatol Res. 2024 May 22;316(5):190. doi: 10.1007/s00403-024-02988-0.
3
Human nonunion tissues display differential gene expression in comparison to physiological fracture callus.

本文引用的文献

1
Risk of postoperative infections and the discontinuation of TNF inhibitors in patients with rheumatoid arthritis: A meta-analysis.类风湿关节炎患者术后感染风险及肿瘤坏死因子抑制剂的停用:一项荟萃分析。
Joint Bone Spine. 2016 Dec;83(6):701-705. doi: 10.1016/j.jbspin.2015.10.019. Epub 2016 Apr 23.
2
Interleukin 6/Wnt interactions in rheumatoid arthritis: interleukin 6 inhibits Wnt signaling in synovial fibroblasts and osteoblasts.类风湿关节炎中白细胞介素6与Wnt信号通路的相互作用:白细胞介素6抑制滑膜成纤维细胞和成骨细胞中的Wnt信号传导。
Croat Med J. 2016 Apr 23;57(2):89-98. doi: 10.3325/cmj.2016.57.89.
3
Rediscovering the therapeutic use of glucocorticoids in rheumatoid arthritis.
与生理性骨折骨痂相比,人非愈合组织显示出不同的基因表达。
Bone. 2024 Jun;183:117091. doi: 10.1016/j.bone.2024.117091. Epub 2024 Apr 2.
4
Genetic in situ engineering of myeloid regulatory cells controls inflammation in autoimmunity.髓系调节细胞的遗传原位工程控制自身免疫中的炎症。
J Control Release. 2021 Nov 10;339:553-561. doi: 10.1016/j.jconrel.2021.08.040. Epub 2021 Aug 24.
5
A Novel Approach to Safer Glucocorticoid Receptor-Targeted Anti-lymphoma Therapy via REDD1 (Regulated in Development and DNA Damage 1) Inhibition.一种通过 REDD1(发育和 DNA 损伤调节 1)抑制实现更安全的糖皮质激素受体靶向抗淋巴瘤治疗的新方法。
Mol Cancer Ther. 2020 Sep;19(9):1898-1908. doi: 10.1158/1535-7163.MCT-19-1111. Epub 2020 Jun 16.
6
Advances in treatment of glucocorticoid-induced osteoporosis.糖皮质激素性骨质疏松症的治疗进展
Curr Opin Endocrinol Diabetes Obes. 2017 Dec;24(6):411-417. doi: 10.1097/MED.0000000000000368.
重新发现糖皮质激素在类风湿关节炎中的治疗用途。
Curr Opin Rheumatol. 2016 May;28(3):289-96. doi: 10.1097/BOR.0000000000000278.
4
Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis.了解细胞因子在类风湿性关节炎发病机制中的作用。
Clin Chim Acta. 2016 Apr 1;455:161-71. doi: 10.1016/j.cca.2016.02.010. Epub 2016 Feb 13.
5
Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden.类风湿关节炎、抗肿瘤坏死因子治疗与鳞状细胞癌和基底细胞皮肤癌风险:基于瑞典全国前瞻性记录数据的队列研究
BMJ. 2016 Jan 28;352:i262. doi: 10.1136/bmj.i262.
6
Treating to target in established rheumatoid arthritis: Challenges and opportunities in an era of novel targeted therapies and biosimilars.在确诊的类风湿关节炎中达标治疗:新型靶向疗法和生物类似药时代的挑战与机遇
Best Pract Res Clin Rheumatol. 2015 Aug-Dec;29(4-5):543-9. doi: 10.1016/j.berh.2015.10.001.
7
Successes and failures of chemokine-pathway targeting in rheumatoid arthritis.趋化因子通路靶向治疗类风湿关节炎的成败。
Nat Rev Rheumatol. 2016 Jan;12(1):5-13. doi: 10.1038/nrrheum.2015.157. Epub 2015 Nov 26.
8
Bone and TNF in rheumatoid arthritis: clinical implications.类风湿关节炎中的骨与 TNF:临床意义。
RMD Open. 2015 Aug 15;1(Suppl 1):e000065. doi: 10.1136/rmdopen-2015-000065. eCollection 2015.
9
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.2015 年美国风湿病学会类风湿关节炎治疗指南。
Arthritis Rheumatol. 2016 Jan;68(1):1-26. doi: 10.1002/art.39480. Epub 2015 Nov 6.
10
Increased Eotaxin and MCP-1 Levels in Serum from Individuals with Periodontitis and in Human Gingival Fibroblasts Exposed to Pro-Inflammatory Cytokines.牙周炎患者血清及暴露于促炎细胞因子的人牙龈成纤维细胞中嗜酸性粒细胞趋化因子和单核细胞趋化蛋白-1水平升高。
PLoS One. 2015 Aug 4;10(8):e0134608. doi: 10.1371/journal.pone.0134608. eCollection 2015.